Notable examples include mutual exclusivity between: mutations in PI(3)K signaling pathway and amplification of PRDM2 (and PDPN) in glioblastoma; mutations in p53, GATA3 and cadherin genes in breast cancer. This evidence concerns the gene TP53 and glioblastoma.